Effective Oral Delivery of Teriparatide Using Organoclay—Polymethacrylate Nanocomposites for Osteoporosis Therapy

Background: Although teriparatide is efficacious, its once-daily subcutaneous injections cause local adverse events, inconvenience, and higher cost, limiting long-term adherence. Therefore, this research aims to engineer a pH-responsive oral formulation of teriparatide for osteoporosis therapy. Methods: A layered silicate nanocomplex was obtained by spontaneous self-assembly of teriparatide (Teri) with 3-aminopropyl magnesium phyllosilicate (AC). The nanocomplex (AC-Teri) was then coated with a 1:1 blend of two polymethacrylic acid derivatives (Eudragit® L100 and Eudragit® S 100) to provide pH-triggered drug release along the gastrointestinal tract. Results: AC-Teri and the coated nanocomplex (EE/AC-Teri) displayed high encapsulation efficiency (>90%) with narrow size distributions. In a stepwise buffer transition system, EE/AC-Teri demonstrated pH-dependent release, with less than 25% drug liberated at pH 1.2, approximately 54% at pH 6.8, and 74% at pH 7.4 over 24 h. Particle size and ζ-potential of EE/AC-Teri shifted in parallel with dissolution of the outer polymer shell. EE/AC-Teri also protected the peptide against enzymatic degradation, preserving the secondary structure of encapsulated teriparatide in simulated intestinal fluids. Compared with free drug, EE/AC-Teri enhanced transcellular drug permeation 2.7-fold in Caco-2 cells. In dexamethasone-induced osteoporotic rats, oral EE/AC-Teri significantly stimulated bone formation while suppressing resorption; micro-CT and histology confirmed recovery of trabecular architecture. Conclusions: EE/AC-Teri represents a promising oral teriparatide formulation for the effective management of osteoporosis.

• Publication year

  2025

• Venue

  Pharmaceutics

• Publication date

  2025-11-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.3390/pharmaceutics17111450PMID 41304788PMCID 12655526
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An oral robotic pill reliably and safely delivers teriparatide with high bioavailability in healthy volunteers: A phase 1 study

  2025cited by this paper
• Evidence-Based Guideline for the management of osteoporosis in men

  2024cited by this paper
• Enhanced Oral Efficacy of Semaglutide via an Ionic Nanocomplex with Organometallic Phyllosilicate in Type 2 Diabetic Rats

  2024cited by this paper
• Layered silicate nanoparticles as a non-injectable drug delivery system for biomacromolecules

  2024cited by this paper
• Fabrication and Evaluation of a pH-Responsive Nanocomposite-Based Colonic Delivery System for Improving the Oral Efficacy of Liraglutide

  2023influential reference
• Enhanced oral absorption of teriparatide with therapeutic potential for management of osteoporosis.

  2022cited by this paper
• Bisphosphonates Targeting Ion Channels and Musculoskeletal Effects

  2022cited by this paper
• Cell-surface glycosaminoglycans regulate the cellular uptake of charged polystyrene nanoparticles.

  2022cited by this paper
• Anabolic therapy for osteoporosis: update on efficacy and safety

  2022cited by this paper
• Bone Matrix Non-Collagenous Proteins in Tissue Engineering: Creating New Bone by Mimicking the Extracellular Matrix

  2021cited by this paper
• Oral controlled release dosage forms: dissolution versus diffusion

  2020cited by this paper
• Novel Magnesium Aminoclay-Vitamin C Hybrid for Enhanced Stability and Bioactivity in Cosmeceutical Applications.

  2020cited by this paper
• Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation

  2020cited by this paper
• Mechanical regulation of bone homeostasis through p130Cas-mediated alleviation of NF-κB activity

  2019cited by this paper
• Dysregulation of ectonucleotidase-mediated extracellular adenosine during postmenopausal bone loss

  2019influential reference
• Development of pH-responsive organic-inorganic hybrid nanocomposites as an effective oral delivery system of protein drugs.

  2019cited by this paper
• Overexpression of Recombinant Human Teriparatide, rhPTH (1–34) in Escherichia coli : An Innovative Gene Fusion Approach

  2017cited by this paper
• Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization

  2017influential reference
• An overview and management of osteoporosis.

  2017cited by this paper
• A novel aminoclay-curcumin hybrid for enhanced chemotherapy.

  2016cited by this paper
• Biophysical evaluation of aminoclay as an effective protectant for protein stabilization during freeze-drying and storage

  2016cited by this paper
• Teriparatide for osteoporosis: importance of the full course

  2016cited by this paper
• Management principles of osteoporotic fractures.

  2016cited by this paper
• Using Micro-CT Derived Bone Microarchitecture to Analyze Bone Stiffness – A Case Study on Osteoporosis Rat Bone

  2015cited by this paper
• Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway

  2015cited by this paper
• The natural approach to osteoporosis.

  2015cited by this paper
• ORAL DELIVERY OF INSULIN USING COMPOSITE POLYMERIC MICROPARTICLES

  2014influential reference
• Steroid-induced hypocalcaemia with tetany in a patient with hypoparathyroidism

  2014cited by this paper
• Aminoclay: a functional layered material with multifaceted applications

  2013cited by this paper
• Pharmacokinetics of Oral Recombinant Human Parathyroid Hormone [rhPTH(1–31)NH2] in Postmenopausal Women with Osteoporosis

  2013cited by this paper
• Drug carriers in osteoporosis: preparation, drug encapsulation and applications.

  2013cited by this paper
• 3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofen

  2013cited by this paper
• Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum.

  2012cited by this paper
• pH-enzyme di-dependent chronotherapeutic drug delivery system of theophylline for nocturnal asthma.

  2011cited by this paper
• Antihypertensive peptides: production, bioavailability and incorporation into foods.

  2011cited by this paper
• Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis

  2010cited by this paper
• Self-assembly of bio–inorganic nanohybrids using organoclay building blocks

  2008cited by this paper
• Patient treatment preferences for osteoporosis.

  2006cited by this paper
• Synthesis and self-assembly of organoclay-wrapped biomolecules.

  2004cited by this paper
• The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation

  2003cited by this paper
• Tartrate‐Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone Resorption

  2000cited by this paper

• No citing papers are available for this paper.